ANTI-CYCLIC CITRULLINATED PEPTIDE (ANTI-CCP) - ANVISA Registration 80213250567

Access comprehensive regulatory information for ANTI-CYCLIC CITRULLINATED PEPTIDE (ANTI-CCP) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80213250567 and manufactured by AXIS-SHIELD DIAGNOSTICS LTD. The registration is held by PHAREBEE DIAGNOSTICOS COMERCIO IMPORTACAO E EXPORTACAO DE PRODUTOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT GMBH, BIO - RAD LABORATORIES INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.